Home/Filings/4/0001628280-25-057669
4//SEC Filing

Bispham Barbara Harlin 4

Accession 0001628280-25-057669

CIK 0001253689other

Filed

Dec 16, 7:00 PM ET

Accepted

Dec 17, 4:35 PM ET

Size

8.9 KB

Accession

0001628280-25-057669

Insider Transaction Report

Form 4
Period: 2025-12-15
Transactions
  • Award

    Ordinary Shares

    2025-12-15+12,42212,422 total
  • Award

    Ordinary Shares

    2025-12-15+6,00018,422 total
  • Award

    Stock Option (Right to Buy)

    2025-12-15+72,18572,185 total
    Exercise: $13.21Exp: 2035-12-15Ordinary Shares (72,185 underlying)
Footnotes (2)
  • [F1]Represents an award of Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Ordinary Shares. The RSUs shall vest in approximately equal three-month installments through the four-year anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.
  • [F2]This Option represents a right to purchase shares of the Issuer's Ordinary Shares and vests with respect to 1/48th of the Option on each monthly anniversary of December 15, 2025, subject to the Reporting Person remaining continuously employed by or providing services to the Issuer or its subsidiaries from December 15, 2025 through each such vesting date.

Issuer

CRESCENT BIOPHARMA, INC.

CIK 0001253689

Entity typeother

Related Parties

1
  • filerCIK 0002075230

Filing Metadata

Form type
4
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 4:35 PM ET
Size
8.9 KB